Multiplicom is a spin out of the Jurgen Del-Favero lab of the VIB Department of Molecular Genetics at the University of Antwerp (UA), directed by Christine Van Broeckhoven. The company is specialized in the development, manufacturing and commercialization of innovative molecular genetic tests. These tests allow (i) to determine whether an individual has an increased genetic risk to develop a disease, (ii) early detection of congenital genetic defect, or (iii) to identify the most appropriate therapy for patients. Multiplicom’s assays offer a significant overall reduction in cost and time for next generation sequencing based genetic analysis.
Multiplicom already offers several diagnostic assays, including assays for breast cancer and cystic fibrosis. Moreover, Multiplicom is already using its Multiplexer™ technology in collaboration with pharma companies to identify genetic markers linked to drug safety and/or efficacy.
- Activity: molecular diagnostics
- Website: www.multiplicom.com
- Location: Belgium
- Entry: 2011
- Platform: Health & Care